The impact of alcohol-specific conditions on multimorbidity prevalence: A systematic review and meta-analysis
In brief
People with alcohol-related conditions have 2.6 times the odds of multimorbidity
Across 86 studies involving nearly 1.9 million people, 38% of those with alcohol-specific conditions had multiple long-term health conditions. Compared with people without these conditions, their odds of multimorbidity were 2.6 times higher, with a larger gap among those under 45; substantial differences between studies leave the exact prevalence uncertain.
- Journal
- Addiction (Abingdon, England) (Q1)
- Published
- 8 November 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Nina MacKenzie, Joe Schofield, Peter D Donnelly, Colin McCowan, Cicely K Macnamara, Sandhya Duggal, et al.
- PMID
- 43000658
- DOI
- 10.1111/add.70695
Why clinicians should know about it
- Picked for Epidemiology (paper of the day, 10 November 2026): Systematic review estimates multimorbidity prevalence in alcohol conditions
Abstract
BACKGROUND AND AIMS: Multimorbidity, the presence of 2 or more long-term health conditions, and alcohol use disorders are both significant global concerns associated with poor health outcomes and substantial socioeconomic consequences, but their relationship remains under-explored. This study estimated the prevalence of multimorbidity among people with alcohol-specific conditions and compared it to those without alcohol-specific conditions. METHOD: Systematic review, searching six databases for cross-sectional, national surveys, cohort and case-control studies or randomised controlled trials that included a measurement of multimorbidity prevalence in adults with alcohol-specific conditions. The search included all settings (primary care, secondary care, community-based studies) without geographical limits, with data collected up to February 2026. Multimorbidity was defined as 1+ and/or 2+ long-term conditions in addition to alcohol-specific conditions (health conditions wholly attributable to alcohol consumption, as defined by standardised international classification systems). Studies measuring prevalence of individual co-morbidities only, using alcohol disorder screening tools, and those reporting only summary measures via a weighted index score, were excluded. The primary outcome was to estimate the absolute prevalence of multimorbidity in people with alcohol-specific conditions. Secondary outcomes were to compare the prevalence of multimorbidity between individuals with, and without, alcohol-specific conditions, and examine the impact of covariates (including age, sex, number and types of conditions assessed, geographical location, source of data and study quality). Study quality was assessed using adapted appraisal tools from the Joanna Briggs Institute. RESULTS: From 34 756 citations, 364 full texts were reviewed and 86 studies included, featuring 1 885 987 individuals with alcohol-specific conditions. 67 studies reported sex distribution; females comprised on average 26% of study populations. The absolute prevalence of multimorbidity in those with alcohol-specific conditions was 38% [95% confidence interval (CI) = 33-44, number of studies included (k) = 86], with substantial heterogeneity across studies [I2 (estimating the percentage of variation due to heterogeneity rather than chance) = 99.99%]. The odds ratio (OR) of multimorbidity between those with and without alcohol-specific conditions at a threshold of at least two long-term conditions was 2.63 times greater (95% CI = 2.03-3.53, k = 15, P < 0.0001). Comparative prevalence was higher in younger populations with alcohol-specific conditions compared to without (<45 years old, OR = 3.41, 95% CI = 2.17-5.36) than in older populations (≥45 years old, OR = 1.83, 95% CI = 1.36-2.46). SUMMARY: Multimorbidity is common and disproportionately prevalent among people with alcohol-specific conditions, with particularly elevated odds of multimorbidity prevalence in younger cohorts.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.